Cargando…

METTL3 attenuates proliferative vitreoretinopathy and epithelial‐mesenchymal transition of retinal pigment epithelial cells via wnt/β‐catenin pathway

Proliferative vitreoretinopathy (PVR) is a refractory vitreoretinal fibrosis disease, and epithelial‐mesenchymal transition (EMT) of retinal pigment epithelial (RPE) cells is the key pathological mechanism of PVR. However, few studies focused on the role of METTL3, the dominating methyltransferase f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Xinqi, Long, Chongde, Wang, Fangyu, Lou, Bingsheng, Yuan, Miner, Duan, Fang, Yang, Yao, Li, Jiaqing, Qian, Xiaobing, Zeng, Jieting, Lin, Shuibin, Shen, Huangxuan, Lin, Xiaofeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093987/ https://www.ncbi.nlm.nih.gov/pubmed/33759344 http://dx.doi.org/10.1111/jcmm.16476

Ejemplares similares

Polarity and epithelial-mesenchymal transition of retinal pigment epithelial cells in proliferative vitreoretinopathy
por: Zou, Hui, et al.
Publicado: (2020)

Silibinin Prevents TGFβ-Induced EMT of RPE in Proliferative Vitreoretinopathy by Inhibiting Stat3 and Smad3 Phosphorylation
por: Ma, Xinqi, et al.
Publicado: (2023)

Exosomes mediate an epithelial‐mesenchymal transition cascade in retinal pigment epithelial cells: Implications for proliferative vitreoretinopathy
por: Zhang, Yao, et al.
Publicado: (2020)

Resveratrol inhibits epithelial-mesenchymal transition of retinal pigment epithelium and development of proliferative vitreoretinopathy
por: Ishikawa, Keijiro, et al.
Publicado: (2015)

Radial Retinotomies with Endodiathermy for Severe Proliferative Vitreoretinopathy: Short-Term Results
por: Jiang, Zhaoxin, et al.
Publicado: (2016)

DAPL1 prevents epithelial–mesenchymal transition in the retinal pigment epithelium and experimental proliferative vitreoretinopathy
por: Ma, Xiaoyin, et al.
Publicado: (2023)

Yes‐associated protein is essential for proliferative vitreoretinopathy development via the epithelial‐mesenchymal transition in retinal pigment epithelial fibrosis
por: Zhang, Wei, et al.
Publicado: (2021)

Long noncoding RNA ERLR mediates epithelial-mesenchymal transition of retinal pigment epithelial cells and promotes experimental proliferative vitreoretinopathy
por: Yang, Shuai, et al.
Publicado: (2021)

Experimental Models to Study Epithelial-Mesenchymal Transition in Proliferative Vitreoretinopathy
por: Datlibagi, Azine, et al.
Publicado: (2023)

Endogenous or Exogenous Retinal Pigment Epithelial Cells: A Comparison of Two Experimental Animal Models of Proliferative Vitreoretinopathy
por: Wong, Chee Wai, et al.
Publicado: (2020)

Epithelial Membrane Protein-2 in Human Proliferative Vitreoretinopathy and Epiretinal Membranes
por: Telander, David G., et al.
Publicado: (2016)

RPE epithelial-mesenchymal transition plays a critical role in the pathogenesis of proliferative vitreoretinopathy
por: Li, Xiaohua, et al.
Publicado: (2020)

Blockage of Notch Signaling Inhibits the Migration and Proliferation of Retinal Pigment Epithelial Cells
por: Liu, Weiwei, et al.
Publicado: (2013)

TNF-α and NF-κB signaling play a critical role in cigarette smoke-induced epithelial-mesenchymal transition of retinal pigment epithelial cells in proliferative vitreoretinopathy
por: Wang, Victor, et al.
Publicado: (2022)

Anti-tumor Drug THZ1 Suppresses TGFβ2-mediated EMT in Lens Epithelial Cells via Notch and TGFβ/Smad Signaling Pathway
por: Ning, Jie, et al.
Publicado: (2019)

Proliferative Vitreoretinopathy and Genetic Profile
por: Ghasemi Falavarjani, Khalil
Publicado: (2013)

Proliferative Vitreoretinopathy: A Reappraisal
por: Carpineto, Paolo, et al.
Publicado: (2023)

Trichostatin A Inhibits Retinal Pigmented Epithelium Activation in an In Vitro Model of Proliferative Vitreoretinopathy
por: Por, Elaine D., et al.
Publicado: (2016)

Non-viral gene therapy using RNA interference with PDGFR-α mediated epithelial-mesenchymal transformation for proliferative vitreoretinopathy
por: Wang, Jiahao, et al.
Publicado: (2023)

m(6)A methyltransferase METTL3 promotes retinoblastoma progression via PI3K/AKT/mTOR pathway
por: Zhang, Han, et al.
Publicado: (2020)

Repression of Smad4 by MicroRNA-1285 moderates TGF-β-induced epithelial–mesenchymal transition in proliferative vitreoretinopathy
por: Pao, Shu-I, et al.
Publicado: (2021)

A therapeutic perspective for proliferative vitreoretinopathy based on the inhibition of epithelial-mesenchymal transition by miR-194
por: Bencivenga, Maria, et al.
Publicado: (2020)

Proliferative vitreoretinopathy: current and emerging treatments
por: Sadaka, Ama, et al.
Publicado: (2012)

The impact of octreotide in experimental proliferative vitreoretinopathy
por: Evren, Ozge, et al.
Publicado: (2013)

Fulminant proliferative vitreoretinopathy in syphilitic uveitis
por: Queiroz, Rafael de Pinho, et al.
Publicado: (2016)

Intravitreal methotrexate infusion for proliferative vitreoretinopathy
por: Sadaka, Ama, et al.
Publicado: (2016)

Intravitreal methotrexate for the treatment of proliferative vitreoretinopathy
por: Benner, Jeffrey David, et al.
Publicado: (2019)

MeCP2‐421‐mediated RPE epithelial‐mesenchymal transition and its relevance to the pathogenesis of proliferative vitreoretinopathy
por: Li, Xiaohua, et al.
Publicado: (2020)

Overexpression p21WAF1/CIP1 in suppressing retinal pigment epithelial cells and progression of proliferative vitreoretinopathy via inhibition CDK2 and cyclin E
por: Wang, Ying, et al.
Publicado: (2014)

Doxycycline Ameliorates the Severity of Experimental Proliferative Vitreoretinopathy in Mice
por: Chen, Shun-Hua, et al.
Publicado: (2021)

Introduction of the MDM2 T309G Mutation in Primary Human Retinal Epithelial Cells Enhances Experimental Proliferative Vitreoretinopathy
por: Zhou, Guohong, et al.
Publicado: (2017)

Subretinal Perfluorocarbon Liquid for Dissection of Proliferative Vitreoretinopathy
por: Dalma-Weiszhausz, Jose, et al.
Publicado: (2012)

Evaluation of retinectomy in the treatment of severe proliferative vitreoretinopathy
por: Mendes, Thaís Sousa, et al.
Publicado: (2015)

Retinal shortening: Ultrasonic evaluation of proliferative vitreoretinopathy
por: Takkar, Brijesh, et al.
Publicado: (2017)

Biological Involvement of MicroRNAs in Proliferative Vitreoretinopathy
por: Kaneko, Hiroki, et al.
Publicado: (2017)

Inflammatory and Fibrogenic Factors in Proliferative Vitreoretinopathy Development
por: Chaudhary, Rishika, et al.
Publicado: (2020)

Inflammatory mediators of proliferative vitreoretinopathy: hypothesis and review
por: Dai, Ying, et al.
Publicado: (2020)

Curcumin Inhibits Proliferation and Epithelial-Mesenchymal Transition in Lens Epithelial Cells through Multiple Pathways
por: Liu, Huijun, et al.
Publicado: (2020)

TSPAN4-positive migrasome derived from retinal pigmented epithelium cells contributes to the development of proliferative vitreoretinopathy
por: Wu, Liangjing, et al.
Publicado: (2022)

Interleukin-6 promotes proliferative vitreoretinopathy by inducing epithelial-mesenchymal transition via the JAK1/STAT3 signaling pathway
por: Chen, Xiaoyun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2l9ilnef9vkqo2235li4t09nrd